Circio (Gm-Csf Vaccine Adjuvant in Lysaker, Norway) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Asset Purch.

  • Financing Rounds
  • 1

Circio (Gm-Csf Vaccine Adjuvant in Lysaker, Norway) General Information

Description

GM-CSF vaccine adjuvant based in Lysaker, Norway.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Lysaker
  • Norway
Primary Industry
Buildings and Property
Other Industries
Drug Discovery
Acquirer
Hubro Therapeutics
Corporate Office
  • Lysaker
  • Norway

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Circio (Gm-Csf Vaccine Adjuvant in Lysaker, Norway) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Circio (Gm-Csf Vaccine Adjuvant in Lysaker, Norway)‘s full profile, request access.

Request a free trial

Circio (Gm-Csf Vaccine Adjuvant in Lysaker, Norway) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Circio (Gm-Csf Vaccine Adjuvant in Lysaker, Norway)‘s full profile, request access.

Request a free trial

Circio (Gm-Csf Vaccine Adjuvant in Lysaker, Norway) FAQs

  • Where is Circio (Gm-Csf Vaccine Adjuvant in Lysaker, Norway) headquartered?

    Circio (Gm-Csf Vaccine Adjuvant in Lysaker, Norway) is headquartered in Lysaker, Norway.

  • What industry is Circio (Gm-Csf Vaccine Adjuvant in Lysaker, Norway) in?

    Circio (Gm-Csf Vaccine Adjuvant in Lysaker, Norway)’s primary industry is Buildings and Property.

  • Is Circio (Gm-Csf Vaccine Adjuvant in Lysaker, Norway) a private or public company?

    Circio (Gm-Csf Vaccine Adjuvant in Lysaker, Norway) is a Private company.

  • What is the current valuation of Circio (Gm-Csf Vaccine Adjuvant in Lysaker, Norway)?

    The current valuation of Circio (Gm-Csf Vaccine Adjuvant in Lysaker, Norway) is .

  • What is Circio (Gm-Csf Vaccine Adjuvant in Lysaker, Norway)’s current revenue?

    The current revenue for Circio (Gm-Csf Vaccine Adjuvant in Lysaker, Norway) is .

  • Who are Circio (Gm-Csf Vaccine Adjuvant in Lysaker, Norway)’s investors?

    Circio Holding has invested in Circio (Gm-Csf Vaccine Adjuvant in Lysaker, Norway).

  • When was Circio (Gm-Csf Vaccine Adjuvant in Lysaker, Norway) acquired?

    Circio (Gm-Csf Vaccine Adjuvant in Lysaker, Norway) was acquired on 01-Nov-2022.

  • Who acquired Circio (Gm-Csf Vaccine Adjuvant in Lysaker, Norway)?

    Circio (Gm-Csf Vaccine Adjuvant in Lysaker, Norway) was acquired by Hubro Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process